Phase II evaluation of mitozolomide in ovarian cancer

Br J Cancer. 1988 Jan;57(1):113-4. doi: 10.1038/bjc.1988.21.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Drug Evaluation
  • Female
  • Humans
  • Leukopenia / chemically induced
  • Middle Aged
  • Nitrogen Mustard Compounds / adverse effects
  • Nitrogen Mustard Compounds / therapeutic use*
  • Ovarian Neoplasms / drug therapy*
  • Thrombocytopenia / chemically induced

Substances

  • Antineoplastic Agents
  • Nitrogen Mustard Compounds
  • mitozolomide